Dooti Roy
Dr. Dooti Roy is an Executive Director of Global Biostatistics and Data Sciences at Boehringer Ingelheim where she wears dual hats.
In her role as the Head of Innovation, Clinical Data Science, Dooti along with her leadership team, defines and delivers the innovation strategy across Statistics, Statistical Programming, and Data Science — ensuring that scientific, methodological, and technological advances translate into measurable impact for clinical development and business outcomes.
In her role as the U.S. Head of Clinical Data Science, she is a passionate people developer who loves mentoring and nurturing world-class talents to build and shape future scientific and technical experts and leaders to deliver value and partnership to the larger organization and beyond.
As a scientist and a statistician, Dooti is deeply committed to pioneering and promoting data-driven innovations and fit-for-purpose equitable solutions to accelerate quality drug development.
She has an adjunct faculty appointment at the University of Connecticut and serve in various capacities in several cross-industry working groups and associations.
Junxian Geng
Dr. Junxian Geng is a director, biostatistics at Servier leading a team focusing on HTA/HEOR and medical affairs analysis. Before he joined Servier, he worked as a biostatistician in Daiichi Sankyo for around 1 year and Boehringer Ingelheim for around 7 years. He graduated from the statistics department in Florida State University with a PhD degree in statistics, where his research focused on Nonparametric Bayesian Data Analysis. Since he started his career in the pharmaceutical industry, he has been focusing on developing/implementing novel statistical methods to design various types of oncology studies, including dose findings studies, studies with basket design as well as seamless phase 2/3 studies.